- Home
- HBAN vs MDLN Comparison
HBAN vs MDLN Comparison
Compare HBAN & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBAN | MDLN |
|---|---|---|
| Founded | 1866 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 36.3B | 30.7B |
| IPO Year | 2010 | 2025 |
Fundamental Metrics
Financial Performance| Metric | HBAN | MDLN |
|---|---|---|
| Price | $15.17 | $34.95 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 20 | 27 |
| Target Price | $19.75 | ★ $44.60 |
| AVG Volume (30 Days) | ★ 25.6M | 6.8M |
| Earning Date | 10-22-2026 | 08-05-2026 |
| Dividend Yield | ★ 4.06% | N/A |
| EPS Growth | ★ 13.93 | N/A |
| EPS | ★ 0.25 | 0.23 |
| Revenue | $1,562,000,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $35.97 | $9.85 |
| Revenue Next Year | $6.95 | $7.82 |
| P/E Ratio | ★ $61.36 | $151.74 |
| Revenue Growth | 6.40 | ★ 11.47 |
| 52 Week Low | $14.89 | $31.49 |
| 52 Week High | $19.44 | $50.88 |
Technical Indicators
Market Signals| Indicator | HBAN | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 28.06 | 53.04 |
| Support Level | $15.00 | $32.47 |
| Resistance Level | $18.20 | $37.39 |
| Average True Range (ATR) | 0.37 | 1.14 |
| MACD | -0.07 | 0.34 |
| Stochastic Oscillator | 0.00 | 85.78 |
Price Performance
Historical ComparisonAbout HBAN Huntington Bancshares Incorporated
Huntington is a regional US bank with over $285 billion in assets. It offers a full suite of consumer deposit and lending services, along with commercial services focused on payments, investment management, capital markets, equipment financing, treasury management, and other common banking services.
About MDLN Medline Inc. Class A Common Stock
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.